Xvivo Perfusion Reports Q2 Revenue of $239M with Strong Growth in Thoracic and Abdominal Sales
Xvivo Perfusion AB reported second-quarter revenue of $239 million. The company saw a 53% increase in thoracic sales (in local currencies) and a 26% rise in abdominal sales, while services sales declined.
Topics: revenue sales_growth